Inside the HK Market: Infrastructure Dividends, Biotech Moves and Sector OverhaulsGlobal Report·9 hours ago00905-3.26%00368-1.81%
Beyond the Spotlight: The Silent Rebuilding of Hong Kong's Diverse Equities in 2026Global Report·12 hours ago06865-1.64%08066-1.72%
Divergent Signals in Hong Kong's Periphery: Shippers Expand as Tech RestructuresGlobal Report·Sep 8 at 11:32 AM011760.00%06178-0.77%
Traditional HK Stocks Diverge: Golden Throat Rebounds While CNBM SlipsGlobal Report·Sep 8 at 10:20 AM06896-3.02%02198-2.00%
Earnings Data Send Divergent Signals on Industrial Demand and Cross-Border RisksGlobal Report·Sep 8 at 09:18 AM01641-1.77%02198-2.00%
Corporate Restructurings and Divergent Earnings Highlight Mixed Recovery in Hong KongGlobal Report·Sep 1 at 11:32 AM01943+1.26%01489+1.75%
Inside the Diverging Fortunes of Asia's Tech and Defense SectorsGlobal Report·Sep 1 at 09:18 AM01611-3.51%02442+9.50%
CHINA SANJIANG Interim Net Profit Up 117.9% YoY to RMB656 million; Div 10 HK CentsAASTOCKS News·Aug 26 at 10:41 AM02198-2.00%
China Sanjiang Fine Chemicals FY26 1H net profit more than doubles to RMB 656.1 million; revenue rises 5.4% to RMB 9.6 billionPUBT·Aug 26 at 10:29 AM02198-2.00%
The Hong Kong Junk Drawer: Ignore the Noise and Follow the Cash FlowGlobal Report·Aug 25 at 11:34 AM83690-0.16%02575-2.12%
Inside the Fringes of HKEX: Tencent's RMB Counter and Overhauls in Non-Mainstream EquitiesGlobal Report·Aug 25 at 09:21 AM02570-7.29%80700+1.68%
Earnings Divergence: Nine Dragons and Sanjiang Surge as GOME Struggles with Debt PileGlobal Report·Aug 18 at 09:43 AM09609-2.77%02198-2.00%
Tech M&A and Capital Restructuring Define Early 2026 Moves Across Hong Kong EquitiesGlobal Report·Aug 11 at 09:43 AM02533+3.60%02137-0.57%
China Sanjiang Fine Chemicals sets board meeting to review interim results, consider dividendPUBT·Aug 7 at 08:56 AM02198-2.00%
I'm Told: Inside the Radical Overhauls of Hong Kong's Under-the-Radar StocksGlobal Report·Jul 28 at 09:12 AM01757+0.10%01119-3.70%
